Quick Answer
LISATA THERAPEUTICS, INC. reported Total Assets of $17.74 million for the year ending 2025.
- LISATA THERAPEUTICS, INC. showed a decrease of -49.3% in Total Assets from 2024 to 2025.
- This data is from LISATA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $170.33 million | Q3 2011: $168.21 million | Q1 2012: $167.28 million | Q2 2012: $138.03 million | Q3 2012: $128.81 million | Q1 2013: $49.90 million | Q2 2013: $53.61 million | Q3 2013: $57.79 million | Q1 2014: $86.39 million | Q2 2014: $133.40 million | Q3 2014: $131.34 million | Q1 2015: $118.81 million | Q2 2015: $128.62 million | Q3 2015: $119.70 million | Q1 2016: $63.18 million | Q2 2016: $56.71 million | Q3 2016: $57.28 million | Q1 2017: $48.53 million | Q2 2017: $72.25 million | Q3 2017: $67.56 million | Q1 2018: $56.72 million | Q2 2018: $52.09 million | Q3 2018: $47.85 million | Q1 2019: $41.29 million | Q2 2019: $36.35 million | Q3 2019: $31.67 million | Q1 2020: $22.14 million | Q2 2020: $37.48 million | Q3 2020: $42.02 million | Q1 2021: $114.61 million | Q2 2021: $108.61 million | Q3 2021: $102.54 million | Q1 2022: $91.46 million | Q2 2022: $85.88 million | Q3 2022: $78.53 million | Q1 2023: $66.33 million | Q2 2023: $62.37 million | Q3 2023: $58.09 million | Q1 2024: $48.24 million | Q2 2024: $42.57 million | Q3 2024: $38.20 million | Q1 2025: $28.98 million | Q2 2025: $25.16 million | Q3 2025: $21.76 million.
- Over the full 16 years of available data (2010 to 2025), LISATA THERAPEUTICS, INC.'s Total Assets has declined by 87.6%.
- Historical annual values: Fiscal year 2025: $17.74 million | Fiscal year 2024: $35.00 million | Fiscal year 2023: $54.69 million | Fiscal year 2022: $73.03 million | Fiscal year 2021: $97.01 million | Fiscal year 2020: $36.00 million | Fiscal year 2019: $27.15 million | Fiscal year 2018: $44.58 million | Fiscal year 2017: $63.38 million | Fiscal year 2016: $53.51 million | Fiscal year 2015: $57.21 million | Fiscal year 2014: $126.28 million | Fiscal year 2013: $89.82 million | Fiscal year 2012: $54.41 million | Fiscal year 2011: $155.33 million | Fiscal year 2010: $143.02 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: